All In Biotech

Drugs by condition

Drugs approved for tardive dyskinesia

Brand-name prescription drugs and biologics whose FDA label lists tardive dyskinesia as an approved use. Matched on the label phrases: "tardive dyskinesia".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

6

Still marketed, NDA or BLA

Drug classes

1

Novel drugs

2

New molecular entities and new biologics

In development

2

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for tardive dyskinesia.

  • Ingrezza Sprinkle (Valbenazine Tosylate) · Neurocrine OrphanApr 30, 2024
  • Austedo Xr (Deutetrabenazine) · Teva OrphanFeb 17, 2023
  • Gimoti (Metoclopramide Hydrochloride) · Qol Medcl Jun 19, 2020
  • Ingrezza (Valbenazine Tosylate) · Neurocrine NovelBreakthrough therapyPriority reviewOrphanApr 11, 2017
  • Austedo (Deutetrabenazine) · Teva Branded Pharm NovelOrphanApr 3, 2017

All approved drugs for tardive dyskinesia, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 33 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Class not listed in FDA's data (6)

  • Ingrezza Valbenazine Tosylate · Neurocrine · 2017
  • Austedo Deutetrabenazine · Teva Branded Pharm · 2017
  • Ingrezza Sprinkle Valbenazine Tosylate · Neurocrine · 2024
  • Austedo Xr Deutetrabenazine · Teva · 2023
  • Gimoti Metoclopramide Hydrochloride · Qol Medcl · 2020
  • Reglan Metoclopramide Hydrochloride · Ani Pharms · 1980

Drugs in development for tardive dyskinesia

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline

More on tardive dyskinesia: recruiting trials · published research

Related in neurology: Alzheimer's disease · Parkinson's disease · Multiple sclerosis · Epilepsy and seizures · Migraine · ALS (amyotrophic lateral sclerosis) · Myasthenia gravis · Spinal muscular atrophy · Duchenne muscular dystrophy · Huntington's disease chorea

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.